Wai-Kay Seto

机构：Chinese University of Hong Kong, State Key Laboratory of Chemical Engineering, University of Hong Kong

发表论文 6 篇 · 总被引 8 次 · h-index 2

代表论文

• Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort (2026 · Journal of Hepatology · 被引 6)
• Lack of association between rifaximin and drug-resistant infections: a global multicenter inpatient cirrhosis cohort (2026 · Clinical and Molecular Hepatology · 被引 3)
• Mass hepatitis C virus screening among persons in custody in Hong Kong: a modelling cost-effectiveness analysis based on a prospective cohort study (2026 · The Lancet Regional Health - Western Pacific)
• Challenges, progress, and prospects of drug discovery to treat chronic hepatitis B infection (2026 · Elsevier eBooks)
• Contributors (2026 · Elsevier eBooks)
• Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium. (2023 · Repository@Nottingham (University of Nottingham))